Oppilotech Overview

Founded 2014
Status Private
Latest Deal Type Accelerator/​Inc
Latest Deal Amount $120K
Latest Deal Amount
Investors 3

Oppilotech General Information


Developer of novel antibacterial compounds and antibiotics intended to work drug resistant organisms. The company's bacterial cell envelope bio-genesis and new antibacterial drugs is intended to identify potential drugs that hit the target and disrupt the cell envelope, increasing its permeability.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • London Bioscience Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oppilotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 30-Mar-2017 $120K Completed Startup
1. Angel (individual) Completed Startup

Oppilotech Executive Team (2)

Name Title Board Seat Contact Info
Ajay Mistry Ph.D Co-Founder & Chief Executive Officer
John George Co-Founder & Chief Scientific Officer

Oppilotech Investors (3)

To view Oppilotech‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CARB-X Government 000 0000 000000 0
Angels in Med City Angel Group Minority 000 0000 000000 0
O2h Ventures Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial